Shimadzu’s MultiNA II MCE-301 streamlines nucleic acid analysis with automated workflow, real-time data review and support ...
Zoldonrasib, an investigational therapy designed to inhibit the KRAS G12D mutation, has produced high tumour response rates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results